PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.94%
Net income growth above 1.5x MCHP's 5.61%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
0.33%
Some D&A expansion while MCHP is negative at -5.85%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
52.63%
Well above MCHP's 87.37% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-19.48%
Both cut yoy SBC, with MCHP at -8.54%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
165.88%
Slight usage while MCHP is negative at -90.32%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
125.45%
AR growth is negative or stable vs. MCHP's 257.09%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
76.67%
Inventory growth well above MCHP's 108.35%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
18.64%
A yoy AP increase while MCHP is negative at -235.82%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
18200.00%
Some yoy usage while MCHP is negative at -381.20%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
130.00%
Lower 'other non-cash' growth vs. MCHP's 449.03%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
78.45%
Some CFO growth while MCHP is negative at -0.68%. John Neff would note a short-term liquidity lead over the competitor.
-28.75%
Negative yoy CapEx while MCHP is 11.36%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
28.75%
Acquisition growth of 28.75% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-69.64%
Negative yoy purchasing while MCHP stands at 27.98%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-68.16%
We reduce yoy sales while MCHP is 13.38%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-18.18%
Both yoy lines negative, with MCHP at -0.20%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-147.76%
We reduce yoy invests while MCHP stands at 62.81%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment 1.25-1.5x MCHP's 66.97%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-45.60%
Negative yoy issuance while MCHP is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
9.83%
We have some buyback growth while MCHP is negative at -42.09%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.